Denmark· DK-28104745510

Komboglyze

A metformin and saxagliptin product containing metforminhydrochlorid, saxagliptinhydrochlorid, registered in Denmark by AstraZeneca AB. The same ATC class is registered in 12 of our 19 countries.

ATC A10BD10

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedKomboglyzeATCA10BD10REGISTER NO.DK-28104745510PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Metformin and saxagliptin is registered in 12 of 19 countries.

Countries holding a registration under ATC A10BD10 (metformin and saxagliptin), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 7 of them publish a price we can compare per daily dose

Metformin and saxagliptin · ATC A10BD10

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
METFORMINHYDROCHLORID, Saxagliptinhydrochlorid
Manufacturer
AstraZeneca AB
Country
Denmark (DK)
ATC code
A10BD10
ATC class
Metformin and saxagliptin
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28104745510

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for metformin and saxagliptin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Metformin and saxagliptin · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d233952b-bec2-41d6-b356-751742e27c40
GET /v1/drugs/d233952b-bec2-41d6-b356-751742e27c40?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "filmovertrukne tabletter",
  "source": "dkma",
  "strength": "2,5mg+850mg",
  "auth_role": "MOD",
  "dk_drugid": "28104745510",
  "substance": "METFORMINHYDROCHLORID, Saxagliptinhydrochlorid",
  "auth_procedure": "Central",
  "in_medicinpriser": false,
  "registration_date_serial": "41206"
}

See everything about metformin and saxagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.